Fangzhou has signed a MoU with Novo Nordisk to collaborate on the management of serious chronic diseases, including obesity and diabetes.

Dr. Xie Fangmin remarked, “We are partnering with Novo Nordisk, a leading global healthcare company, to explore AI technology ...

Fangzhou's recent deployment of the DeepSeek open-source large language model in February has set the stage for this partnership, which utilises Tencent Cloud's infrastructure to power the AI ...

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced the successful integration and local deployment of the DeepSeek-R1 open-source large ...

GUANGZHOU, China, May 29, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, took center stage at the 4th Annual "Internet ...

HONG KONG, March 23, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced on March 21st, 2025 its financial results for ...

Aug 17 (Reuters) - Huaxun Fangzhou Co Ltd: * SAYS IT AIMS TO RAISE UP TO 1.1 BILLION YUAN ($159.92 million) IN PRIVATE PLACEMENT OF SHARES TO FUND PROJECTS, REPLENISH CAPITAL Source text in ...

Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of December 31, 2024).

This summary provides an overview of the most significant critical numbers from each of the Fangzhou financial reports, including the Fangzhou Inc. income statement, balance sheet, and cash flow ...